Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 31537528

Minimal residual disease undetectable by next-generation sequencing predicts improved outcome in CLL after chemoimmunotherapy.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Blood
Publication date
2019 Nov 28
First author
Thompson PA

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Blood. 2019 Nov 28;134(22):1883-1884. doi: 10.1182/blood.2019003244.
    note
    Source null
    related pmid
    31778541
    relationship
    Comment in

Authors and identifiers

  1. name
    Thompson PA
    type
    Author
  2. name
    Srivastava J
    type
    Author
  3. name
    Peterson C
    type
    Author
  4. name
    Strati P
    type
    Author
  5. name
    Jorgensen JL
    type
    Author
  6. name
    Hether T
    type
    Author
  7. name
    Keating MJ
    type
    Author
  8. name
    O'Brien SM
    type
    Author
  9. name
    Ferrajoli A
    type
    Author
  10. name
    Burger JA
    type
    Author
  11. name
    Estrov Z
    type
    Author
  12. name
    Jain N
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Thompson PA
    type
    Author
  2. name
    Srivastava J
    type
    Author
  3. name
    Peterson C
    type
    Author
  4. name
    Strati P
    type
    Author
  5. name
    Jorgensen JL
    type
    Author
  6. name
    Hether T
    type
    Author
  7. name
    Keating MJ
    type
    Author
  8. name
    O'Brien SM
    type
    Author
  9. name
    Ferrajoli A
    type
    Author
  10. name
    Burger JA
    type
    Author
  11. name
    Estrov Z
    type
    Author
  12. name
    Jain N
    type
    Author
bibliography ids
  1. nci-bib-85b213c169b5d13b69dc2140
book metadata
content sha256
e9a7ae493378066b2ffef0b1585c45c4489d273e40d39dccf0fa3207c8a9cf85
document type
citation
dois
  1. 10.1182/blood.2019001077
electronic publication date
display
Source null
precision
missing
year
Source null
evidence scope
bibliographic_metadata_only
id
pubmed:31537528
immutable id
pubmed:31537528@e9a7ae493378066b2ffef0b1585c45c4489d273e40d39dccf0fa3207c8a9cf85
journal
abbreviation
Blood
issn electronic
1528-0020
issn print
0006-4971
issue
22
name
Blood
nlm unique id
7603509
pages
1951-1959
volume
134
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Blood. 2019 Nov 28;134(22):1883-1884. doi: 10.1182/blood.2019003244.
    note
    Source null
    related pmid
    31778541
    relationship
    Comment in
outcomes validated
false
pmid
31537528
provenance
batch id
23ffe1e2a9e160b6dca0
provider
NCBI PubMed ESummary
record sha256
70a34695bc5489226cc3d6d7845e9146e3ca27656c77c037331c358c6c05b280
response sha256
d5cbfde8f87ba85b214c53aaf0e8fa33d70fec48dd4fde7745538180cd7e1841
retrieved at
2026-09-09T23:47:44.690737+00:00
publication date
display
2019 Nov 28
precision
day
year
2019
publication types
  1. Clinical Trial, Phase II
  2. Journal Article
  3. Multicenter Study
  4. Research Support, N.I.H., Extramural
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/31537528/
title
Minimal residual disease undetectable by next-generation sequencing predicts improved outcome in CLL after chemoimmunotherapy.

Preserved source evidence · Not medical advice